Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthetic technological process of bilobalide B derivates

A technology of ginkgolide and synthesis process, which is applied in the field of medicine, can solve problems such as actual production operations, safety hazards, and retention, and achieve the effects of cost simplification, cost reduction, and increased reaction rate

Active Publication Date: 2012-04-25
JIANGSU CAREFREE PHARM CO LTD
View PDF5 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its synthesis method only stays in the experimental stage, and the output is very small and limited to the gram level. The synthesis process needs to involve strong reducing agent sodium hydride and inert gas protection, which brings huge hidden dangers to its actual production operation and safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic technological process of bilobalide B derivates
  • Synthetic technological process of bilobalide B derivates
  • Synthetic technological process of bilobalide B derivates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 11

[0013] The above-mentioned content of the present invention will be further described in detail through the embodiments represented by several specific examples below, but it should not be understood that the scope of the subject matter of the present invention is only limited to the following specific examples. The preparation of embodiment 110-O-(dimethylaminoethyl) ginkgolide B

[0014] 250g (0.59mol) of ginkgolide B was dissolved in 8.6L of acetonitrile, followed by adding 130g of dimethylaminoethyl chloride hydrochloride, 800g of potassium carbonate, 100g of potassium iodide, and 20g of tetrabutylammonium bromide, and heated to reflux for 1 hour. The reaction is almost complete. Cool, filter, and concentrate the filtrate under reduced pressure to obtain a crude solid. The crude product was purified, recrystallized from methanol, and dried to obtain 117 g of solid (yield 40%).

[0015] Reaction route:

[0016]

Embodiment 210

[0017] The preparation of embodiment 210-O-(N-ethyl morpholinyl) ginkgolide B

[0018] 60g (0.14mol) of ginkgolide B was dissolved in 4L of acetonitrile, followed by adding 37g of N-(2-chloroethyl)morpholine hydrochloride, 250g of potassium carbonate, 25g of potassium iodide, cetyltrimethylammonium bromide 20g, heated to reflux until the reaction is almost complete. Cool, filter, and concentrate the filtrate under reduced pressure to obtain a crude solid. The crude product was purified, recrystallized from methanol, and dried to obtain 37 g of solid (yield 49%).

[0019] Reaction route:

[0020]

Embodiment 310

[0021] The preparation of embodiment 310-O-(diethylaminoethyl) ginkgolide B

[0022] 250g (0.59mol) of ginkgolide B was dissolved in 8.6L of tetrahydrofuran, followed by adding 155g of diethylamino ethyl chloride hydrochloride, 800g of potassium carbonate, 100g of potassium iodide, and 18g of triethylbenzyl ammonium chloride, and heated to reflux for 1 Hours, the reaction was almost complete. Cool, filter, and concentrate the filtrate under reduced pressure to obtain a crude solid. The crude product was purified, recrystallized from methanol, and dried to obtain 125 g of solid (yield 41%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a technological method for synthesizing a bilobalide B derivative. Under alkaline condition and presence of an organic solvent, a homogeneous catalyst and a compound of X-R1-N (R2)-R3 are added for reaction to obtain a derivative after the C10 hydroxyl of the bilobalide B is etherified, wherein, X represents halogen, R1, R2 and R3 represent alkane or naphthenic hydrocarbon with 1-8 carbon atoms and decorate the C10 hydroxyl of the bilobalide B. The technological method for synthesizing the bilobalide B derivative of the invention is safe, economical and applicable to industrialized production, thus bring promising prospect to the market-oriented development of the bilobalide B.

Description

technical field [0001] The invention relates to a synthesis process for a class of compounds, in particular to a synthesis process for derivatives of ginkgolide B, and belongs to the technical field of medicine. Background technique [0002] Ginkgo biloba has been used as a medicinal plant for a long time. Around 1000 AD, Chinese folks used ginkgo leaves to treat asthma and bronchitis. With the standardization of drug extraction process and the in-depth study of pharmacological activity, countries all over the world, especially European countries such as Germany and France, have widely used Ginkgo biloba extract (GBE) to treat respiratory system, cardiovascular and cerebrovascular system and other diseases. Ginkgolides are a series of diterpenoid compounds present in Ginkgo biloba leaves and rhizomes, and their chemical properties are quite stable. Ginkgolide is a strong antagonist of platelet-activating factor (PAF), which is a strong physiological regulator and plays an i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D493/22
Inventor 秦引林
Owner JIANGSU CAREFREE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com